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Cellular memory — conversion of a transient signal into a
sustained response — is a common feature of biological
systems. Synthetic biologists aim tounderstand and re-en-
gineer such systems in a reliable and predictable manner.
Synthetic memory circuits have been designed and built
in vitro and in vivo based on diverse mechanisms, such as
oligonucleotide hybridization, recombination, transcrip-
tion, phosphorylation, and RNA editing. Thus far, building
these circuits has helped us explore the basic principles
required for stable memory and ask novel biological ques-
tions. Here we discuss strategies for building synthetic
memory circuits, their use as research tools, and future
applications of these devices in medicine and industry.
Introduction
Synthetic biology encompasses a vast range of pursuits,
including building novel transcriptional circuits [1,2], engi-
neering metabolism on a large scale [3], and creating a
minimal cell [1,2,4]. Early projects were mostly limited to
building small genetic circuits consisting of only a few parts
[1–3,5]; however, current work has extended our range to
large multi-gene devices [6] and even entire genomes [7].
While some of the first synthetic circuits were built from a
small number of parts, they exhibited complex behavior,
including oscillations and pattern formation [5]. Cellular
memory circuits were also among these early synthetic de-
vices [1]. Cellularmemory refers to the cell’s ability to convert
a transient signal or stimulus into a sustained response (see
Box 1 for a glossary of definition of terms used in this article).
Biological phenomena that rely on natural memory circuits
include the lambda phage switch, cellular differentiation,
and cell division [8,9]. Synthetic memory circuits can either
require active cellular processes to maintain their state (vol-
atile memory) or not (non-volatile memory). Volatile memory
circuits include transcription-based devices, while non-vola-
tile memory circuits can be based on DNA recombination. An
important feature of volatile memory circuits is that they are
bistable — they tend to exist in one of two states. Also, sto-
chastic switching between the stable states should be rare
[10]. Additionally, the change in state of both volatile and
non-volatile memory circuits can be reversible or
irreversible (Figure 1A).
Synthetic memory circuits can be engineered using a
variety of biological mechanisms, including nucleic acid
hybridization, DNA recombination, chromatin modification,
transcription, and post-transcriptional phenomena. Here
we will explore the current state of engineered memory cir-
cuits and their applications. We will then discuss the future
of these devices in medicine and industry.In Vitro Memory Circuits
Synthetic genetic circuits can be constructed in vitro. These
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more complex mixtures of DNA and purified enzymes that
can carry out transcription and translation [12,13]. The
advantage of building synthetic circuits in vitro is the high
level of control over the environment in which the device
will function [14]. This control results in increased pre-
dictability and allows careful unpacking and analysis of
the specific interactions between circuit components. This
detailed understanding should allow better predictions
and interpretations of the behavior of the device when it is
introduced into the more complex worlds of the cell and
multicellular organisms.
In particular, there have been several recent examples of
in vitro toggle switches and memory devices based on
hybridization of oligonucleotides. One such circuit was built
by engineering two mutually repressive DNA-hybridization-
based transcriptional switches [12]. This circuit consists of
DNA oligonucleotides, and two enzymes: T7 RNA poly-
merase and RNase H. The presence of activating single-
stranded (ss) DNA, complementary to each switch, allows
T7 RNA polymerase to transcribe inhibitory RNAs to the
opposing switches, while RNase H degrades the inhibitory
RNAs. By carefully balancing production and degradation
rates, bistable behavior is observed: depending on the initial
amounts of the opposing activating ssDNAs, production of
one inhibitory RNA will completely suppress production of
the other. Importantly, these results agree very closely with
model predictions. While this system is bistable, it is not
switchable; the circuit output depends entirely on the initial
state of the system [12].
While reversibility is not necessary for a synthetic mem-
ory device, it may prove a useful feature. Recently, an
in vitro switchable memory circuit was engineered consist-
ing of DNA oligonucleotides, DNA polymerase, an endonu-
clease, and an exonuclease [13]. The bistable core of the
circuit consists of four templates: two positive feedback
loops, and two mutually repressive feedback loops. There
are two additional templates that produce two activating
oligonucleotides in response to external signals. In this
case, these signals are the addition of additional comple-
mentary oligonucleotides. Each of these oligonucleotides
interacts with the templates in the bistable core to
promote their own production and repress production of
the other. Thus, by adding the appropriate external stim-
ulus, the circuit can be switched from one state to the
other (Figure 1B).
While, in principle, these in vitromemory circuits could be
modified to function in cells, these strategies for engineering
bistability remain unexplored in vivo. However, these studies
have produced extremely detailed mechanistic understand-
ing that will benefit future efforts to transfer these devices
into the cellular environment.
Writing Cellular Memory into DNA
Heritable memory encoded at the DNA level has been used
in biological studies for many years [15]. Developmental
biologists use recombinase systems, such as Cre–loxP
recombination, to permanently mark cells of a given lineage,
and to knock-out genes in specific cell types or at desired
times [16,17]. To accomplish this, transgenic animals are
created carrying circuits in which a reporter gene is inter-
rupted by a transcriptional terminator flanked by loxP sites
Box 1
Glossary.
Bistable: A system that returns to one of two stable states after
perturbation.
Circuit: A group of interacting parts (e.g. promoters, genes,
proteins, oligonucleotides) engineered to integrate one or more
inputs to produce a desired output.
Logic gate: A device that performs logical operations such as
AND, OR, NOT, NOR, NAND, XOR, XNOR.
Memory: A long-lasting and/or permanent change in state of a
system in response to a transient signal.
Toggle switch: A genetic circuit that can be switched repeatedly
between two states (e.g. ON/OFF).
Special Issue
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version [16]. Cre recombinase expression is then put under
the control of a tissue-specific or inducible promoter. Differ-
entiation into a specific tissue or addition of an exogenous
inducer results in expression of Cre, which excises the DNA
between the loxP sites, either creating a functional reporter
gene or removing the gene of interest, respectively. As a
recombination event results in a changeat theDNAsequence
level, the change is irreversible and transmits memory of the
stimulus heritably and permanently (Figure 1C).
By using invertases instead of standard recombinases,
more complex multi-state memory circuits can be designed
[18–20] (Figure 1C). For instance, a double-inversion recom-
bination switch was built in Escherichia coli by constructing
a plasmid with two overlapping inversion modules [18]. A
separate plasmid carried the two inducible invertase genes.
The state of this device can be probed by using a carefully
chosen set of primers. The presence or absence of certain
amplicons not only indicates whether each inducer has
been added, but also the order in which they were intro-
duced. More recently, memory circuits have been integrated
with logic gates by flanking combinations of terminators,
promoters, or reporter genes by two different pairs of recom-
binase target sites [19,21]. Depending on the arrangement
of these elements, all input logic gates (AND, OR, NOR,
and NAND) can be created. Additionally, multiple inversion-
based memory circuits can be linked to build a genetic
counter capable of indicating the number of pulses of
inducer experienced by the cell [22]. As with the systems
used in lineage tracing experiments [16,17], activation of
these devices is irreversible.
Recently a rewritable recombination-based memory
device was demonstrated in E. coli. This recombinase
addressable data (RAD) module consists of a promoter
flanked by phage attachment sites, attB and attP, situated
between two fluorescent protein genes [20]. The device is
‘set’ by expression of a phage integrase (Int), inverting
the DNA between the attB and attP sites and converting
these to attL and attR sites. The device is reset by coex-
pression of Int and the corresponding excisionase (Xis),
flipping the DNA between attL and attR sites and restoring
the attB and attP sites. Depending on the orientation of the
promoter, one of the two fluorescent proteins is produced.
The state of the device is stable over many generations
and can be switched back and forth reliably many times.
A reversible memory circuit enables the design of acombinatorial genetic counter [23]. In contrast to a counter
built from irreversible memory circuits — using N modules
for N counts — a combinatorial counter with N modules
can count to 2N [23].
Transmitting Memory through Transcriptional Networks
The vast majority of synthetic genetic circuits implemented
in vivo rely on the successful engineering of transcriptional
regulation. One of the best-understood transcriptional
regulation systems, lambda phage, is an example of a natural
memory circuit [8]. As such, several synthetic memory
circuits are transcription based [1,2,24–27]. There are two
main gene network topologies that can demonstrate sus-
tained memory behavior; double-negative feedback loops,
and a positive feedback loop [10] (Figure 1D). Both of these
strategies have been explored in different contexts and
each has advantages and disadvantages. While the latter is
a much simpler circuit with fewer components to engineer,
the former, by virtue of its increased complexity, provides
more options for modification and tuning.
An early example of a synthetic genetic circuit was an en-
gineered toggle switch in E. coli [1]. Inspired by the natural
lambda phage immunity region [8], which had previously
been shown to function in a novel context [28], a double-
negative feedback circuit was constructed, consisting of
two repressors driven by constitutive promoters. Each
repressor can repress synthesis of the other; therefore,
when one repressor is expressed, the other is repressed,
thereby creating two stable states. Importantly, it is possible
to selectively inactivate each repressor by the addition of a
specific small molecule, permitting the device to switch
states. Careful tuning of promoter strength based on the
choice of repressor created toggle switches that demon-
strated bistability and long-term memory. Later, similar syn-
thetic toggle switches were shown to function in mammalian
cells, demonstrating the modularity of the design [24,29].
Recently, a toggle switch was combined with genetic logic
circuits to create a switch that can be switched on and off
by repeated addition of a single trigger molecule [25].
While several autoregulatory circuits were built having
some degree of bistability [30–32], the first positive feedback
loop that predictably and reliably transmitted memory for
many cell divisions was built in Saccharomyces cerevisiae
[2]. To create this device, the activities of several transcrip-
tion factors under the control of a galactose-inducible pro-
moter were characterized and a computational model of
the circuit was used to predict which of these would form a
functional memory circuit. Indeed, the model correctly pre-
dicted which of the transcription factors would succeed
and which would fail. This memory device was later shown
to be modular; when the galactose-inducible promoter was
replaced with the promoter for a gene encoding a protein
involved in the DNA repair response, the circuit maintained
its activity, albeit while responding to DNA damage instead
of galactose [26]. This re-engineered circuit was able to iden-
tify a subpopulation of cells that maintained a differential
response to DNA damage for many generations after expo-
sure to damage. As with the toggle switch, the modularity
of the positive-feedback-based memory device extends to
its transferability to a different organism. A similar device
designed to respond to either doxycycline, ultraviolet
radiation, or hypoxia was built in human cells and was
successfully used to isolate a subpopulation of cells that
responded differentially to these stimuli [27].
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Figure 1. Cellular memory circuits can be built in many ways.
(A) The change in state of synthetic memory circuits can be either reversible or irreversible. (B) In vitro memory circuits rely on hybridization of
nucleic acids. Interlocking negative and positive feedback loops form the bistable core (in box) of such devices. Once activated, each positive
feedback loop produces an oligonucleotide that promotes its own production as well as an inhibitory oligonucleotide to the opposing positive
feedback loop. (C–F) In vivo memory circuits are built using diverse strategies. (C) Recombination-based memory circuits can be based on
excision or inversion of DNA sequences. (D) Both positive and double-negative transcriptional feedback loops can be used to engineer cellular
memory. Novel memory circuits based on (E) protein phosphorylation and (F) RNA editing have also been proposed.
Current Biology Vol 23 No 17
R814Memory after Transcription
While cellular memory circuits have been engineered that
operate at the DNA sequence level as well as through
regulation of transcription, post-transcriptional processes
have yet to be explored. Natural systems exhibit bistability
and even memory dependent on processes such as phos-
phorylation [33] and post-transcriptional modification of
RNA [34]. Recent efforts to model these systems open the
possibility of harnessing them in engineered circuits.
The phosphorylation state of proteins with multiple
phosphorylation sites has been shown to be switch-like or
bistable [33]. For example, multi-site phosphorylation is
thought to contribute to the bistability of the MAP kinase
cascade [35]. Other models predict that scaffolding is
also a significant contributor to bistable phosphorylation
cascades [36]. Now, synthetic phosphorylation-based cir-
cuits can be built to test these predictions, adding protein
phosphorylation to the selection of tools available for
engineering cellular memory (Figure 1E). This will allow
synthetic biologists to build novel circuits that can respond
on much quicker timescales than transcriptional or recombi-
nation-based circuits.
As another point of post-transcriptional regulation, trans-
lation level and thus protein level can be controlled through
RNA modifications. Recently, construction of a positive
feedback loop dependent on control of mRNA polyadenyla-
tion has been proposed [37] (Figure 1F). Transcripts with
more polyadenylation are more likely to be translated
compared to thosewithout [38,39]. By expressing a polyade-
nylating enzyme from a transcript carrying its cognate poly-
adenylation signal, a positive feedback loop can be created
[37]. This circuit has the potential to be bistable, making it
a candidate for becoming the basis of a cellular memorydevice. These diverse methods of creating cellular memory
will provide a powerful toolkit for building future synthetic
circuits.
Learning through Building
Synthetic biologists have envisioned what may be possible
once we can reliably and predictably re-engineer biology.
While building novel genetic circuits both in vitro and in vivo
has been a pursuit of synthetic biologists for several years,
most of these have yet to find utility in real-world applica-
tions. Nevertheless, these early efforts have proven useful
both as research tools and in gaining a better understanding
of natural biological mechanisms (Figure 2A).
Synthetic memory circuits have been used to explore
what is needed to engineer bistability. In particular,
transcription-based circuits have been extensively modeled
[40–43] and many examples have been built in diverse
contexts [1,2,24–27]. The knowledge gained through these
pursuits will allow synthetic biologists to better understand
natural and novel transcriptional networks. In addition,
memory circuits have been used to study biological ques-
tions that would otherwise be intractable. As described
earlier, recombination-based memory circuits have been
used extensively to trace developmental lineages of cells.
These circuits also allow conditional gene knock-outs,
making it possible to study the effects of gene loss in certain
cell types and at specific times during development [16].
Synthetic memory circuits based on transcriptional posi-
tive feedback loops have been used to study the long-term
effects of transient stimuli in S. cerevisiae and human
cells [26,27]. S. cerevisiae cells carrying the DNA-damage-
responsive memory circuit were exposed to genotoxic
doses of the DNA-damaging agents EMS or hydroxyurea.
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Figure 2. Engineered cellularmemory circuits can be used to study biology andmay be used to diagnose and treat disease, aswell as solve unmet
industrial needs.
(A) Memory circuits can be used to study heterogeneously responding cell populations. (B) When a cell changes from a healthy to a disease state,
memory circuits can detect and report this change or treat the underlying condition. (C) Memory circuits will allow long-term expression by
transient addition of inducer.
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the memory state if they respond above a certain threshold,
allowing isolation of a more strongly responsive subpopu-
lation. This subpopulation was shown to have a higher rate
of mitochondrial activity and iron uptake and this phenotype
persisted for many generations after exposure to the
genotoxic agent [26]. Similarly, a DNA-damage-responsive
memory device in human cells was also used to isolate a
subpopulation of strongly responding cells. Gene expres-
sion in these memory cells differed from the non-memory
population for many days after exposure to UV radiation
[27]. Thus, using synthetic memory circuits, we can mark
and influence biologically relevant subpopulations of cells.
The Future of Engineered Cellular Memory
While synthetic memory devices have been useful in learning
more about biology and the function of genetic networks,
we expect that, in the future, these circuits will find new
applications in fields such as medicine or industrial bio-
technology (Figure 2B,C). Other types of synthetic circuits
and engineered cells are already being explored as potential
next-generation therapies in the treatment of diseases such
as diabetes, metabolic syndrome, and cancer [44–47]. The
ability to induce a sustained response to a transient stimulus
will enable new forms of treatment and diagnosis as well as
meet unsolved industrial challenges [47].
Current medical treatment relies on diagnosis of a disease
before an appropriate treatment can be administered, and
a patient will often have to take repeated doses of a drug
over the course of treatment [48,49]. A synthetic memory
circuit could be engineered to detect a biological signal of
disease and start producing either an easily detectable
reporter or a therapeutic agent (Figure 2B). Transcriptional
positive feedback loops have already been shown to be
modular and thus can be coupled to different biological
signaling pathways to detect transient changes in the biologyof the cell [26]. Alternatively, the device can be engineered to
respond to an extracellular stimulus, such as radiation or
hypoxia. These devices will allow a physician to know
whether a certain stimulus or condition has occurred, even
if it is no longer present. While the output of the memory
device can be an easily detectable reporter, such as a fluoro-
phore, beta-galactosidase, or secreted alkaline phospha-
tase, in the future the output of these devices may be a
therapeutic agent [50]. This will automate both the detection
and treatment of disease, decreasing the time between the
start of the condition and the first dose of therapy (Figure 2B).
Cellular memory devices will also be useful in an industrial
setting. One barrier to cost-effective production of chemical
products is the cost of constantly inducing the culture [19].
A synthetic memory device would convert transient induc-
tion of a large culture into permanent expression of the exog-
enous biosynthetic pathways of interest, significantly
reducing the cost of production [19] (Figure 2C). In addition,
one can imagine designing a synthetic memory circuit to be
activated at a certain cell density or other internal condition,
eliminating the need for an external inducer.
Conclusions
Engineering synthetic memory circuits has already taught
us about designing bistability and building genetic circuits
both in vitro and in vivo, and has helped answer diverse
biological questions. However, there remain unmet needs
that will enable new applications, namely, more diverse
and well-characterized parts — e.g. transcription factors,
recombinases, and inducible promoters — as well as more
predictive models describing the interactions of these parts.
As we apply this deepened understanding and incorporate
new tools, such as phosphorylation and RNA modification,
more complex systems will be designed and implemented,
making these devices an important part of next-generation
medical treatments and bioindustry.
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